Skip to main content
SpringerLink
Log in

The pathogenesis and clinical presentation of macular edema in inflammatory diseases

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Cystoid macular edema (CME) is a classical complication of ocular inflammation. This syndrome was already described by Irvine in 1953 but the pathogenesis of this condition remains unclear. Cystoid macular edema can result either from a rupture of the inner or from the outer blood ocular barrier. Clinical CME that is responsitble for a low visual acuity must be differentiated from angiographic CME that can be present even without any decrease in visual acuity. Fluid progressively accumulates into the outer plexiform layer of the retina and pools into cystic spaces. Fluid accumulation can now be better seen with optical coherence tomography (OCT). In chronic CME fluid accumulation is associated with thinning of the retina and fibrosis. At this stage irreversible lesions are present and CME does not respond to medical therapies. Inflammatory CME must be differentiated from CME resulting from irreversible vascular damage such as in diabetic CME or due to vein occlusions. Experimental research on cystoid macular edema has been hampered by the lack of animal model: most of laboratory animals have no macula, monkeys appear to be highly resistent to macular edema. Five major causes have been suspected to be at the origin of CME: (1) photic retinopathy, (2) trauma of ocular tissue, (3) secondary irritation of the ciliary body, (4) vitreous traction and (5) pharmaceutically induced CME. Clincial experience has shown that pseudophakic CME usually responds well to local therapy of steroids and non-steroidal antiinflammatory drugs (NSAIDs) and/or in association with systemic acetazolamide. Acetazolamide is increasing fluid resorption through the retinal pigment epithelium. Postoperative CME rarely needs additional posterior subtenon's injections to resolve. But in CME occurring secondary to uveitis additional posterior sub-Tenon's steroid injections or systemic steroids may be necessary to decrease the constant release of inflammatory mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 1953; 36(5): 599-619.

    Google Scholar 

  2. Gass JDM, Norton EWD. Cystoid macular edema and papilledema following cataract extraction. Arch Ophthalmol 1966; 76(11): 646-661.

    PubMed  CAS  Google Scholar 

  3. Gutman FA, Zegarra H. Macular edema secondary to occlusion of the retinal veins. Survey of Ophthalmology 1984; 28: 462-70.

    Article  PubMed  Google Scholar 

  4. Yanoff M. Diabetic retinopathy. New England Journal of Medicine 1966; 274: 1344-9.

    Article  PubMed  CAS  Google Scholar 

  5. Miyake K, Sakamura S, Miura H. Long-term follow-up study on prevention of aphakic cystoid macular edema by topical indomethacin. British Journal of Ophthalmology 1980; 64: 324-8.

    PubMed  CAS  Google Scholar 

  6. Kraff MC, Sanders DR, Jampol LM, Peymann GA, Lieberman HL. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 1982; 89: 885-90.

    PubMed  CAS  Google Scholar 

  7. Fleisher LN, Ferrell JB, McGahan MC. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin. Inflammation 1990; 14(3): 325-35.

    Article  PubMed  CAS  Google Scholar 

  8. Guex-Crosier Y, Roberge F. Cytokine injections replicate endotoxin-induced uveitis (EIU). Invest Ophthalmol Vis Sci 1997; 38(4): S191.

    Google Scholar 

  9. Zinn KM, Benjamin-Henkind J. Pigment epithelium. In: teratology Oaea, ed. Retinal pigment epithelium. Philadelphia: Harper and Row publishers, 1982: 533-52.

    Google Scholar 

  10. Raviola G. The structural basis of the blood-ocular barriers. Exp Eye Res 1977; Suppl.: 27-63.

  11. Marmor MF, Abdul-Rahim AS, Cohen SD. The effect of metabolic inhibitors on retinal adhesion and subretinal fluid resorbsion. Invest Ophthalmol Vis Sci 1980; 19(8): 893-903.

    PubMed  CAS  Google Scholar 

  12. Cox NS, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988; 106: 1190-5.

    PubMed  CAS  Google Scholar 

  13. Wolfensberger TJ, Mahieur I, Jarvis-Evans J, et al. Membrane-bound carbonic anhydrase in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1994; 35: 3401-7.

    PubMed  CAS  Google Scholar 

  14. Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989; 107(10): 1445-52.

    PubMed  CAS  Google Scholar 

  15. Chen JC, Fitzke FW, Bird AC. Long-term effect of acetazolamide in a patient with retinitis pigmentosa. Invest Ophthalmol Vis Sci 1990; 31(9): 1914-8.

    PubMed  CAS  Google Scholar 

  16. Tso MOM. Animal modeling of cystoid macular edema. Surv Ophthalmol 1984; 28 (Suppl.)(5): 512-9.

    Article  PubMed  Google Scholar 

  17. Chan CC, Nussenblatt RB, Wiggert B, et al. Immunohistochemical analysis of experimental autoimmune uveoretinitis (EAU) induced by interphotoreceptor retinoid-binding protein (IRBP) in the rat. Immunol Invest 1987; 16(1): 63-74.

    PubMed  CAS  Google Scholar 

  18. Hirose S, Wiggert B, Redmond TM, et al. Uveitis induced in primates by IRBP: Humoral and cellular immune responses. Exp Eye Res 1987; 45: 695-702.

    PubMed  CAS  Google Scholar 

  19. Fox GM, Kuwabara T, Wiggert B, et al. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen. Clin. Immunol Immunopathol 1987; 43(2): 256-64.

    Article  PubMed  CAS  Google Scholar 

  20. Roberge FG, Alexander K, Chan C-C, Martin DF, Nussenblatt RB, De Smet MD. Inhibition of cellular transfer of experimental autoimmune uveoretinitis by rapamycine. Ocular Immunology and Inflammation 1993; 1(3): 269-73.

    Google Scholar 

  21. Guex-Crosier Y, Raber J, Chan C-C, et al. Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. J Immunol 1997; 158: 452-8.

    PubMed  CAS  Google Scholar 

  22. Othenin-Girard P, Pittet N, Herbort CP. La barrière hémato-aqueuse après opération de la cataracte: comparaison de l'implantation dans le sac capsulaire et dans le sulcus. Can J Ophthalmol 1993; 28(2): 55-7.

    PubMed  CAS  Google Scholar 

  23. Othenin-Girard, Tritten J-J, Pittet N, Herbort CP. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. J Cataract Refract Surgery 1994; 20(1): 9-12.

    CAS  Google Scholar 

  24. Guex-Crosier Y, Othenin-Girard P, Herbort CP. Traitement différencié de l'oedème maculaire cystoïde inflammatoire postopératoire et secondaire aux uvéites. Klin. Monatsbl Augenheilkd 1992; 200: 367-73.

    PubMed  CAS  Google Scholar 

  25. Tso M. Photic maculopathy in rhesus monkey. A light and electron microscopic study. Invest Ophthalmol Vis Sci 1973; 12: 17-34.

    CAS  Google Scholar 

  26. McDonald HR, Irvine AR. Light induced maculopathy from the operating microscope in extracapsular cataract extraction and intraocular lens implantation. Ophthalmology 1983; 90: 945-51.

    PubMed  CAS  Google Scholar 

  27. Calkins JL, Hochmeister BF. Retinal exposure from operationg microscope. Arch Ophthalmol 1979; 97: 2363-7.

    PubMed  CAS  Google Scholar 

  28. Henry MM, Henry LM. A possible cause of cyclic maculopathy. Annals Ophthalmology 1977; 9: 455-7.

    CAS  Google Scholar 

  29. Mannis MJ, Becker B. Retinal light exposure and cystoid macular edema. Arch Ophthalmol 1980; 98: 1133.

    PubMed  CAS  Google Scholar 

  30. Bradford JD, Wilkinson CP, Bradford RJ. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 1988; 8(3): 161-4.

    Article  PubMed  CAS  Google Scholar 

  31. Wilkinson CP. A longterm follow-up of cystoid macular edema in aphakic and pseudophakic eyes. Trans Am Ophthalmol Soc 1981; 79(1981): 810-39.

    PubMed  CAS  Google Scholar 

  32. Sholiton DB, Reinart WJ, Frank KE. Indomethacin as a means of preventing cystoid macular edema following intracapsular cataract extraction. Am. Intraocul-Implant Soc J 1979; (5): 137-40.

    CAS  Google Scholar 

  33. Yannuzzi L, Landau AN, Turtz AI. Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology 1981; 88: 947-54.

    PubMed  CAS  Google Scholar 

  34. Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 1990; 97(10): 1253-8.

    PubMed  CAS  Google Scholar 

  35. Quentin C-D, Behrens-Baumann W, Gaus W. Prophylaxe des zystoiden Makulaödems mit Diclofenac-Augentropfen bei i.c. Kataractextraction it Choyce-Mark-IXVorderkammerlinse. Fortschr Ophthalmol 1989; 86: 546-9.

    PubMed  CAS  Google Scholar 

  36. Rausenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989; 16: 792-6.

    Google Scholar 

  37. Bayen H, Bayen MC, De Curzon HP, et al. Involvement of the posterior eye segment in HLA-B27 positive iridocyclitis. Incidence. Value of surgical treatment. J Fr Ophthalmol. 1988; 11: 561-6.

    CAS  Google Scholar 

  38. Smith RE, Nozik RA. Uveitis: A clinical approach to diagnosis and management (2nd ed.). Baltimore: Williams and Wilkins, 1989.

    Google Scholar 

  39. Lautier-Frau M, Grégoire-Cassoux N, Hannouche D, et al. Mise en évidence de l'efficacité des bolus de corticoides par le laser flare meter. Ophtalmologie 1994; 8: 360-3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jules Gonin Eye Hospital, University of Lausanne, Switzerland

    Y. Guex-Crosier

Authors
  1. Y. Guex-Crosier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guex-Crosier, Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 97, 297–309 (1999). https://doi.org/10.1023/A:1002130005227

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1002130005227

Search

Navigation